カテゴリー： LP Information, 世界, 医療/バイオ

世界のDT混合ワクチン市場予測 2021年-2026年

【英語タイトル】Global DT-Based Combined Vaccines Market Growth 2021-2026

LP Informationが出版した調査資料（LPI21MY9514）・商品コード：LPI21MY9514
・発行会社（調査会社）：LP Information
・発行日：2021年5月（※2024年版があります。お問い合わせください）
・ページ数：163
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥541,680見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥812,520見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,083,360見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
LPインフォメーション社の「DT混合ワクチンの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、二種類以上疾患から保護、異なる菌株・血清型による疾患から保護など、用途別には、子供、大人、高齢者、妊娠などにセグメント区分してまとめました。DT混合ワクチンのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・DT混合ワクチンの世界市場概要（サマリー）
・DT混合ワクチンの企業別販売量・売上
・DT混合ワクチンの企業別市場シェア
・DT混合ワクチンの世界市場規模 2016年-2021年：種類別（二種類以上疾患から保護、異なる菌株・血清型による疾患から保護）
・DT混合ワクチンの世界市場規模 2016年-2021年：用途別（子供、大人、高齢者、妊娠）
・DT混合ワクチンの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど）
・DT混合ワクチンのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）
・DT混合ワクチンのヨーロッパ市場規模（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・DT混合ワクチンの中東・アフリカ市場（エジプト、南アフリカ、トルコ、GCC諸国など）
・DT混合ワクチン市場の成長要因・課題・動向
・DT混合ワクチンの世界市場予測 2021年-2026年
・DT混合ワクチンの南北アメリカ市場予測（アメリカ、カナダ、メキシコなど）
・DT混合ワクチンのアジア市場予測（日本、中国、韓国、インド、東南アジアなど）
・DT混合ワクチンのヨーロッパ市場予測（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・DT混合ワクチンの中東・アフリカ市場予測（エジプト、南アフリカ、トルコ、GCC諸国など）
・DT混合ワクチンの世界市場予測：種類別（二種類以上疾患から保護、異なる菌株・血清型による疾患から保護）
・DT混合ワクチンの世界市場予測：用途別（子供、大人、高齢者、妊娠）
・主要企業分析
【レポートの概要】

According to this latest study, the 2020 growth of DT-Based Combined Vaccines will have significant change from previous year. By the most conservative estimates of global DT-Based Combined Vaccines market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the DT-Based Combined Vaccines market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of DT-Based Combined Vaccines market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Protect Against Two or More Diseases
Protect Against One Disease Caused by Different Strains or Serotypes

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Children
Adults
Elderly
Pregnancy

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
GSK
Changsheng
CCBIO
Aleph Biomedical
Sanofi
Lanzhou Institute Of Biological Product
Siobp
Hualan Bio
Tianyuan Bio-Pharma
Vaxtec
Hissen
Abbott
Novartis
Tasly&Jenner
Tiantan

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global DT-Based Combined Vaccines Consumption 2016-2026
2.1.2 DT-Based Combined Vaccines Consumption CAGR by Region
2.2 DT-Based Combined Vaccines Segment by Type
2.2.1 Protect Against Two or More Diseases
2.2.2 Protect Against One Disease Caused by Different Strains or Serotypes
2.3 DT-Based Combined Vaccines Sales by Type
2.3.1 Global DT-Based Combined Vaccines Sales Market Share by Type (2016-2021)
2.3.2 Global DT-Based Combined Vaccines Revenue and Market Share by Type (2016-2021)
2.3.3 Global DT-Based Combined Vaccines Sale Price by Type (2016-2021)
2.4 DT-Based Combined Vaccines Segment by Application
2.4.1 Children
2.4.2 Adults
2.4.3 Elderly
2.4.4 Pregnancy
2.5 DT-Based Combined Vaccines Sales by Application
2.5.1 Global DT-Based Combined Vaccines Sale Market Share by Application (2016-2021)
2.5.2 Global DT-Based Combined Vaccines Revenue and Market Share by Application (2016-2021)
2.5.3 Global DT-Based Combined Vaccines Sale Price by Application (2016-2021)

3 Global DT-Based Combined Vaccines by Company
3.1 Global DT-Based Combined Vaccines Sales Market Share by Company
3.1.1 Global DT-Based Combined Vaccines Sales by Company (2019-2021)
3.1.2 Global DT-Based Combined Vaccines Sales Market Share by Company (2019-2021)
3.2 Global DT-Based Combined Vaccines Revenue Market Share by Company
3.2.1 Global DT-Based Combined Vaccines Revenue by Company (2019-2021)
3.2.2 Global DT-Based Combined Vaccines Revenue Market Share by Company (2019-2021)
3.3 Global DT-Based Combined Vaccines Sale Price by Company
3.4 Global Manufacturers DT-Based Combined Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers DT-Based Combined Vaccines Product Location Distribution
3.4.2 Players DT-Based Combined Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 DT-Based Combined Vaccines by Region
4.1 Global DT-Based Combined Vaccines by Region
4.1.1 Global DT-Based Combined Vaccines Sales by Region
4.1.2 Global DT-Based Combined Vaccines Revenue by Region
4.2 Americas DT-Based Combined Vaccines Sales Growth
4.3 APAC DT-Based Combined Vaccines Sales Growth
4.4 Europe DT-Based Combined Vaccines Sales Growth
4.5 Middle East & Africa DT-Based Combined Vaccines Sales Growth

5 Americas
5.1 Americas DT-Based Combined Vaccines Sales by Country
5.1.1 Americas DT-Based Combined Vaccines Sales by Country (2016-2021)
5.1.2 Americas DT-Based Combined Vaccines Revenue by Country (2016-2021)
5.2 Americas DT-Based Combined Vaccines Sales by Type
5.3 Americas DT-Based Combined Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC DT-Based Combined Vaccines Sales by Region
6.1.1 APAC DT-Based Combined Vaccines Sales by Region (2016-2021)
6.1.2 APAC DT-Based Combined Vaccines Revenue by Region (2016-2021)
6.2 APAC DT-Based Combined Vaccines Sales by Type
6.3 APAC DT-Based Combined Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe DT-Based Combined Vaccines by Country
7.1.1 Europe DT-Based Combined Vaccines Sales by Country (2016-2021)
7.1.2 Europe DT-Based Combined Vaccines Revenue by Country (2016-2021)
7.2 Europe DT-Based Combined Vaccines Sales by Type
7.3 Europe DT-Based Combined Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa DT-Based Combined Vaccines by Country
8.1.1 Middle East & Africa DT-Based Combined Vaccines Sales by Country (2016-2021)
8.1.2 Middle East & Africa DT-Based Combined Vaccines Revenue by Country (2016-2021)
8.2 Middle East & Africa DT-Based Combined Vaccines Sales by Type
8.3 Middle East & Africa DT-Based Combined Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 DT-Based Combined Vaccines Distributors
10.3 DT-Based Combined Vaccines Customer

11 Global DT-Based Combined Vaccines Market Forecast
11.1 Global DT-Based Combined Vaccines Forecast by Region
11.1.1 Global DT-Based Combined Vaccines Forecast by Regions (2021-2026)
11.2.2 Global DT-Based Combined Vaccines Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global DT-Based Combined Vaccines Forecast by Type
11.7 Global DT-Based Combined Vaccines Forecast by Application

12 Key Players Analysis
12.1 GSK
12.1.1 GSK GSK Company Information
12.1.2 GSK DT-Based Combined Vaccines Product Offered
12.1.3 GSK DT-Based Combined Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 GSK Main Business Overview
12.1.5 GSK Latest Developments
12.2 Changsheng
12.2.1 Changsheng Company Information
12.2.2 Changsheng DT-Based Combined Vaccines Product Offered
12.2.3 Changsheng DT-Based Combined Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Changsheng Main Business Overview
12.2.5 Changsheng Latest Developments
12.3 CCBIO
12.3.1 CCBIO Company Information
12.3.2 CCBIO DT-Based Combined Vaccines Product Offered
12.3.3 CCBIO DT-Based Combined Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 CCBIO Main Business Overview
12.3.5 CCBIO Latest Developments
12.4 Aleph Biomedical
12.4.1 Aleph Biomedical Company Information
12.4.2 Aleph Biomedical DT-Based Combined Vaccines Product Offered
12.4.3 Aleph Biomedical DT-Based Combined Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Aleph Biomedical Main Business Overview
12.4.5 Aleph Biomedical Latest Developments
12.5 Sanofi
12.5.1 Sanofi Company Information
12.5.2 Sanofi DT-Based Combined Vaccines Product Offered
12.5.3 Sanofi DT-Based Combined Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Sanofi Main Business Overview
12.5.5 Sanofi Latest Developments
12.6 Lanzhou Institute Of Biological Product
12.6.1 Lanzhou Institute Of Biological Product Company Information
12.6.2 Lanzhou Institute Of Biological Product DT-Based Combined Vaccines Product Offered
12.6.3 Lanzhou Institute Of Biological Product DT-Based Combined Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Lanzhou Institute Of Biological Product Main Business Overview
12.6.5 Lanzhou Institute Of Biological Product Latest Developments
12.7 Siobp
12.7.1 Siobp Company Information
12.7.2 Siobp DT-Based Combined Vaccines Product Offered
12.7.3 Siobp DT-Based Combined Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Siobp Main Business Overview
12.7.5 Siobp Latest Developments
12.8 Hualan Bio
12.8.1 Hualan Bio Company Information
12.8.2 Hualan Bio DT-Based Combined Vaccines Product Offered
12.8.3 Hualan Bio DT-Based Combined Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Hualan Bio Main Business Overview
12.8.5 Hualan Bio Latest Developments
12.9 Tianyuan Bio-Pharma
12.9.1 Tianyuan Bio-Pharma Company Information
12.9.2 Tianyuan Bio-Pharma DT-Based Combined Vaccines Product Offered
12.9.3 Tianyuan Bio-Pharma DT-Based Combined Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Tianyuan Bio-Pharma Main Business Overview
12.9.5 Tianyuan Bio-Pharma Latest Developments
12.10 Vaxtec
12.10.1 Vaxtec Company Information
12.10.2 Vaxtec DT-Based Combined Vaccines Product Offered
12.10.3 Vaxtec DT-Based Combined Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Vaxtec Main Business Overview
12.10.5 Vaxtec Latest Developments
12.11 Hissen
12.11.1 Hissen Company Information
12.11.2 Hissen DT-Based Combined Vaccines Product Offered
12.11.3 Hissen DT-Based Combined Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Hissen Main Business Overview
12.11.5 Hissen Latest Developments
12.12 Abbott
12.12.1 Abbott Company Information
12.12.2 Abbott DT-Based Combined Vaccines Product Offered
12.12.3 Abbott DT-Based Combined Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Abbott Main Business Overview
12.12.5 Abbott Latest Developments
12.13 Novartis
12.13.1 Novartis Company Information
12.13.2 Novartis DT-Based Combined Vaccines Product Offered
12.13.3 Novartis DT-Based Combined Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 Novartis Main Business Overview
12.13.5 Novartis Latest Developments
12.14 Tasly&Jenner
12.14.1 Tasly&Jenner Company Information
12.14.2 Tasly&Jenner DT-Based Combined Vaccines Product Offered
12.14.3 Tasly&Jenner DT-Based Combined Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 Tasly&Jenner Main Business Overview
12.14.5 Tasly&Jenner Latest Developments
12.15 Tiantan
12.15.1 Tiantan Company Information
12.15.2 Tiantan DT-Based Combined Vaccines Product Offered
12.15.3 Tiantan DT-Based Combined Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.15.4 Tiantan Main Business Overview
12.15.5 Tiantan Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. DT-Based Combined Vaccines Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Protect Against Two or More Diseases
Table 3. Major Players of Protect Against One Disease Caused by Different Strains or Serotypes
Table 4. Global DT-Based Combined Vaccines Sales by Type (2016-2021) & (K Doses)
Table 5. Global DT-Based Combined Vaccines Sales Market Share by Type (2016-2021)
Table 6. Global DT-Based Combined Vaccines Revenue by Type (2016-2021) & ($ million)
Table 7. Global DT-Based Combined Vaccines Revenue Market Share by Type (2016-2021)
Table 8. Global DT-Based Combined Vaccines Sale Price by Type (2016-2021)
Table 9. Global DT-Based Combined Vaccines Sales by Application (2016-2021) & (K Doses)
Table 10. Global DT-Based Combined Vaccines Sales Market Share by Application (2016-2021)
Table 11. Global DT-Based Combined Vaccines Value by Application (2016-2021)
Table 12. Global DT-Based Combined Vaccines Revenue Market Share by Application (2016-2021)
Table 13. Global DT-Based Combined Vaccines Sale Price by Application (2016-2021)
Table 14. Global DT-Based Combined Vaccines Sales by Company (2019-2021) & (K Doses)
Table 15. Global DT-Based Combined Vaccines Sales Market Share by Company (2019-2021)
Table 16. Global DT-Based Combined Vaccines Revenue by Company (2019-2021) ($ Millions)
Table 17. Global DT-Based Combined Vaccines Revenue Market Share by Company (2019-2021)
Table 18. Global DT-Based Combined Vaccines Sale Price by Company (2019-2021)
Table 19. Key Manufacturers DT-Based Combined Vaccines Producing Area Distribution and Sales Area
Table 20. Players DT-Based Combined Vaccines Products Offered
Table 21. DT-Based Combined Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global DT-Based Combined Vaccines Sales by Region (2016-2021) (K Doses)
Table 25. Global DT-Based Combined Vaccines Sales Market Share by Region (2016-2021)
Table 26. Global DT-Based Combined Vaccines Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global DT-Based Combined Vaccines Revenue Market Share by Region (2016-2021)
Table 28. Americas DT-Based Combined Vaccines Sales by Country (2016-2021) & (K Doses)
Table 29. Americas DT-Based Combined Vaccines Sales Market Share by Country (2016-2021)
Table 30. Americas DT-Based Combined Vaccines Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas DT-Based Combined Vaccines Revenue Market Share by Country (2016-2021)
Table 32. Americas DT-Based Combined Vaccines Sales by Type (2016-2021) & (K Doses)
Table 33. Americas DT-Based Combined Vaccines Sales Market Share by Type (2016-2021)
Table 34. Americas DT-Based Combined Vaccines Sales by Application (2016-2021) & (K Doses)
Table 35. Americas DT-Based Combined Vaccines Sales Market Share by Application (2016-2021)
Table 36. APAC DT-Based Combined Vaccines Sales by Region (2016-2021) & (K Doses)
Table 37. APAC DT-Based Combined Vaccines Sales Market Share by Region (2016-2021)
Table 38. APAC DT-Based Combined Vaccines Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC DT-Based Combined Vaccines Revenue Market Share by Region (2016-2021)
Table 40. APAC DT-Based Combined Vaccines Sales by Type (2016-2021) & (K Doses)
Table 41. APAC DT-Based Combined Vaccines Sales Market Share by Type (2016-2021)
Table 42. APAC DT-Based Combined Vaccines Sales by Application (2016-2021) & (K Doses)
Table 43. APAC DT-Based Combined Vaccines Sales Market Share by Application (2016-2021)
Table 44. Europe DT-Based Combined Vaccines Sales by Country (2016-2021) & (K Doses)
Table 45. Europe DT-Based Combined Vaccines Sales Market Share by Country (2016-2021)
Table 46. Europe DT-Based Combined Vaccines Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe DT-Based Combined Vaccines Revenue Market Share by Country (2016-2021)
Table 48. Europe DT-Based Combined Vaccines Sales by Type (2016-2021) & (K Doses)
Table 49. Europe DT-Based Combined Vaccines Sales Market Share by Type (2016-2021)
Table 50. Europe DT-Based Combined Vaccines Sales by Application (2016-2021) & (K Doses)
Table 51. Europe DT-Based Combined Vaccines Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa DT-Based Combined Vaccines Sales by Country (2016-2021) & (K Doses)
Table 53. Middle East & Africa DT-Based Combined Vaccines Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa DT-Based Combined Vaccines Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa DT-Based Combined Vaccines Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa DT-Based Combined Vaccines Sales by Type (2016-2021) & (K Doses)
Table 57. Middle East & Africa DT-Based Combined Vaccines Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa DT-Based Combined Vaccines Sales by Application (2016-2021) & (K Doses)
Table 59. Middle East & Africa DT-Based Combined Vaccines Sales Market Share by Application (2016-2021)
Table 60. Global DT-Based Combined Vaccines Sales Forecast by Type (2021-2026) & (K Doses)
Table 61. Global DT-Based Combined Vaccines Sales Market Share Forecast by Type (2021-2026)
Table 62. Global DT-Based Combined Vaccines Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 63. Global DT-Based Combined Vaccines Revenue Market Share Forecast by Type (2021-2026)
Table 64. Global DT-Based Combined Vaccines Sales Forecast by Application (2021-2026) & (K Doses)
Table 65. Global DT-Based Combined Vaccines Sales Market Share Forecast by Application (2021-2026)
Table 66. Global DT-Based Combined Vaccines Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 67. Global DT-Based Combined Vaccines Revenue Market Share Forecast by Application (2021-2026)
Table 68. GSK Basic Information, DT-Based Combined Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 69. GSK DT-Based Combined Vaccines Product Offered
Table 70. GSK DT-Based Combined Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 71. GSK Main Business
Table 72. GSK Latest Developments
Table 73. Changsheng Basic Information, DT-Based Combined Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 74. Changsheng DT-Based Combined Vaccines Product Offered
Table 75. Changsheng DT-Based Combined Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 76. Changsheng Main Business
Table 77. Changsheng Latest Developments
Table 78. CCBIO Basic Information, DT-Based Combined Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 79. CCBIO DT-Based Combined Vaccines Product Offered
Table 80. CCBIO DT-Based Combined Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 81. CCBIO Main Business
Table 82. CCBIO Latest Developments
Table 83. Aleph Biomedical Basic Information, DT-Based Combined Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 84. Aleph Biomedical DT-Based Combined Vaccines Product Offered
Table 85. Aleph Biomedical DT-Based Combined Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 86. Aleph Biomedical Main Business
Table 87. Aleph Biomedical Latest Developments
Table 88. Sanofi Basic Information, DT-Based Combined Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 89. Sanofi DT-Based Combined Vaccines Product Offered
Table 90. Sanofi DT-Based Combined Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 91. Sanofi Main Business
Table 92. Sanofi Latest Developments
Table 93. Lanzhou Institute Of Biological Product Basic Information, DT-Based Combined Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 94. Lanzhou Institute Of Biological Product DT-Based Combined Vaccines Product Offered
Table 95. Lanzhou Institute Of Biological Product DT-Based Combined Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 96. Lanzhou Institute Of Biological Product Main Business
Table 97. Lanzhou Institute Of Biological Product Latest Developments
Table 98. Siobp Basic Information, DT-Based Combined Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 99. Siobp DT-Based Combined Vaccines Product Offered
Table 100. Siobp DT-Based Combined Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 101. Siobp Main Business
Table 102. Siobp Latest Developments
Table 103. Hualan Bio Basic Information, DT-Based Combined Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 104. Hualan Bio DT-Based Combined Vaccines Product Offered
Table 105. Hualan Bio DT-Based Combined Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 106. Hualan Bio Main Business
Table 107. Hualan Bio Latest Developments
Table 108. Tianyuan Bio-Pharma Basic Information, DT-Based Combined Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 109. Tianyuan Bio-Pharma DT-Based Combined Vaccines Product Offered
Table 110. Tianyuan Bio-Pharma DT-Based Combined Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 111. Tianyuan Bio-Pharma Main Business
Table 112. Tianyuan Bio-Pharma Latest Developments
Table 113. Vaxtec Basic Information, DT-Based Combined Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 114. Vaxtec DT-Based Combined Vaccines Product Offered
Table 115. Vaxtec DT-Based Combined Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 116. Vaxtec Main Business
Table 117. Vaxtec Latest Developments
Table 118. Hissen Basic Information, DT-Based Combined Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 119. Hissen DT-Based Combined Vaccines Product Offered
Table 120. Hissen DT-Based Combined Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 121. Hissen Main Business
Table 122. Hissen Latest Developments
Table 123. Abbott Basic Information, DT-Based Combined Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 124. Abbott DT-Based Combined Vaccines Product Offered
Table 125. Abbott DT-Based Combined Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 126. Abbott Main Business
Table 127. Abbott Latest Developments
Table 128. Novartis Basic Information, DT-Based Combined Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 129. Novartis DT-Based Combined Vaccines Product Offered
Table 130. Novartis DT-Based Combined Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 131. Novartis Main Business
Table 132. Novartis Latest Developments
Table 133. Tasly&Jenner Basic Information, DT-Based Combined Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 134. Tasly&Jenner DT-Based Combined Vaccines Product Offered
Table 135. Tasly&Jenner DT-Based Combined Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 136. Tasly&Jenner Main Business
Table 137. Tasly&Jenner Latest Developments
Table 138. Tiantan Basic Information, DT-Based Combined Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 139. Tiantan DT-Based Combined Vaccines Product Offered
Table 140. Tiantan DT-Based Combined Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 141. Tiantan Main Business
Table 142. Tiantan Latest Developments
List of Figures
Figure 1. Picture of DT-Based Combined Vaccines
Figure 2. DT-Based Combined Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global DT-Based Combined Vaccines Sales Growth Rate 2016-2026 (K Doses)
Figure 7. Global DT-Based Combined Vaccines Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. DT-Based Combined Vaccines Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Protect Against Two or More Diseases
Figure 10. Product Picture of Protect Against One Disease Caused by Different Strains or Serotypes
Figure 11. Global DT-Based Combined Vaccines Sales Market Share by Type in 2020
Figure 12. Global DT-Based Combined Vaccines Revenue Market Share by Type (2016-2021)
Figure 13. DT-Based Combined Vaccines Consumed in Children
Figure 14. Global DT-Based Combined Vaccines Market: Children (2016-2021) & (K Doses)
Figure 15. DT-Based Combined Vaccines Consumed in Adults
Figure 16. Global DT-Based Combined Vaccines Market: Adults (2016-2021) & (K Doses)
Figure 17. DT-Based Combined Vaccines Consumed in Elderly
Figure 18. Global DT-Based Combined Vaccines Market: Elderly (2016-2021) & (K Doses)
Figure 19. DT-Based Combined Vaccines Consumed in Pregnancy
Figure 20. Global DT-Based Combined Vaccines Market: Pregnancy (2016-2021) & (K Doses)
Figure 21. Global DT-Based Combined Vaccines Sales Market Share by Application (2016-2021)
Figure 22. Global DT-Based Combined Vaccines Revenue Market Share by Application in 2020
Figure 23. Global DT-Based Combined Vaccines Revenue Market by Company in 2020 ($ Million)
Figure 24. Global DT-Based Combined Vaccines Revenue Market Share by Company in 2020
Figure 25. Global DT-Based Combined Vaccines Sales Market Share by Regions (2016-2021)
Figure 26. Global DT-Based Combined Vaccines Revenue Market Share by Region in 2020
Figure 27. Americas DT-Based Combined Vaccines Sales 2016-2021 (K Doses)
Figure 28. Americas DT-Based Combined Vaccines Revenue 2016-2021 ($ Millions)
Figure 29. APAC DT-Based Combined Vaccines Sales 2016-2021 (K Doses)
Figure 30. APAC DT-Based Combined Vaccines Revenue 2016-2021 ($ Millions)
Figure 31. Europe DT-Based Combined Vaccines Sales 2016-2021 (K Doses)
Figure 32. Europe DT-Based Combined Vaccines Revenue 2016-2021 ($ Millions)
Figure 33. Middle East & Africa DT-Based Combined Vaccines Sales 2016-2021 (K Doses)
Figure 34. Middle East & Africa DT-Based Combined Vaccines Revenue 2016-2021 ($ Millions)
Figure 35. Americas DT-Based Combined Vaccines Sales Market Share by Country in 2020
Figure 36. Americas DT-Based Combined Vaccines Revenue Market Share by Country in 2020
Figure 37. Americas DT-Based Combined Vaccines Sales Market Share by Type in 2020
Figure 38. Americas DT-Based Combined Vaccines Sales Market Share by Application in 2020
Figure 39. United States DT-Based Combined Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 40. Canada DT-Based Combined Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 41. Mexico DT-Based Combined Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 42. Brazil DT-Based Combined Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 43. APAC DT-Based Combined Vaccines Sales Market Share by Region in 2020
Figure 44. APAC DT-Based Combined Vaccines Revenue Market Share by Regions in 2020
Figure 45. APAC DT-Based Combined Vaccines Sales Market Share by Type in 2020
Figure 46. APAC DT-Based Combined Vaccines Sales Market Share by Application in 2020
Figure 47. China DT-Based Combined Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 48. Japan DT-Based Combined Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 49. Korea DT-Based Combined Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 50. Southeast Asia DT-Based Combined Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 51. India DT-Based Combined Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 52. Australia DT-Based Combined Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 53. Europe DT-Based Combined Vaccines Sales Market Share by Country in 2020
Figure 54. Europe DT-Based Combined Vaccines Revenue Market Share by Country in 2020
Figure 55. Europe DT-Based Combined Vaccines Sales Market Share by Type in 2020
Figure 56. Europe DT-Based Combined Vaccines Sales Market Share by Application in 2020
Figure 57. Germany DT-Based Combined Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 58. France DT-Based Combined Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 59. UK DT-Based Combined Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 60. Italy DT-Based Combined Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 61. Russia DT-Based Combined Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 62. Middle East & Africa DT-Based Combined Vaccines Sales Market Share by Country in 2020
Figure 63. Middle East & Africa DT-Based Combined Vaccines Revenue Market Share by Country in 2020
Figure 64. Middle East & Africa DT-Based Combined Vaccines Sales Market Share by Type in 2020
Figure 65. Middle East & Africa DT-Based Combined Vaccines Sales Market Share by Application in 2020
Figure 66. Egypt DT-Based Combined Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 67. South Africa DT-Based Combined Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 68. Israel DT-Based Combined Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 69. Turkey DT-Based Combined Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 70. GCC Country DT-Based Combined Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles


★調査レポート[世界のDT混合ワクチン市場予測 2021年-2026年] (コード：LPI21MY9514)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のDT混合ワクチン市場予測 2021年-2026年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の脊髄くも膜下硬膜外（CSE）併用トレイ市場予測 2021年-2026年
    LPI21MY8849 / LP Information / 2021年5月 / LPインフォメーション社の「脊髄くも膜下硬膜外（CSE）併用トレイの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、標準型、カスタマイズ型など、用途別には、病院、クリニック、外来手術センターなどにセグメント区分してまとめました。脊髄くも膜下硬膜外（CSE）併用トレイのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・脊髄くも膜下硬膜外（CSE）併用トレイの世界市場概要（サマリー） ・脊髄くも膜下硬膜外（CSE）併用トレイの企業別販売量・売上 ・脊髄くも膜下硬膜外（CSE）併用トレイの企業別市場シェア ・脊髄くも膜下硬膜外（CSE）併用トレイの世界市場規模 2016年-2021年：種類別（標準型、カスタマイズ型） ・脊髄くも膜下硬膜外（CSE）併用トレイの世界市場規模 2016年-2021年：用途別（病院、クリニック、外来手術センター） ・脊髄くも膜下硬膜外（CSE）併用トレイの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・脊髄くも膜下硬膜外（CSE）併用トレイのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Combined Spinal and Epidural (CSE) Trays will have significant change from previous year. By the most conservative estimates of global Combined Spinal and Epidural (CSE) Trays market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Combined Spinal and Epidural (CSE) Trays market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth...
  • 世界の複合ホルモン避妊薬市場予測 2021年-2026年
    LPI21MY9487 / LP Information / 2021年5月 / LPインフォメーション社の「複合ホルモン避妊薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、15〜24歳、25〜34歳、35〜44歳、44歳以上など、用途別には、病院、家庭、クリニックなどにセグメント区分してまとめました。複合ホルモン避妊薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・複合ホルモン避妊薬の世界市場概要（サマリー） ・複合ホルモン避妊薬の企業別販売量・売上 ・複合ホルモン避妊薬の企業別市場シェア ・複合ホルモン避妊薬の世界市場規模 2016年-2021年：種類別（15〜24歳、25〜34歳、35〜44歳、44歳以上） ・複合ホルモン避妊薬の世界市場規模 2016年-2021年：用途別（病院、家庭、クリニック） ・複合ホルモン避妊薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・複合ホルモン避妊薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Combined Hormonal Contraceptives will have significant change from previous year. By the most conservative estimates of global Combined Hormonal Contraceptives market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 17400 million in 2019. Over the next five years the Combined Hormonal Contraceptives market will register a 3.4% CAGR in terms of revenue, the global market size will reach US$ 19890 million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Combined Hormonal Contraceptives market by product type,...
  • 世界のB型肝炎ワクチン市場予測 2021年-2026年
    LPI21MY9631 / LP Information / 2021年5月 / LPインフォメーション社の「B型肝炎ワクチンの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、酵母由来、CHO由来など、用途別には、子供、大人などにセグメント区分してまとめました。B型肝炎ワクチンのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・B型肝炎ワクチンの世界市場概要（サマリー） ・B型肝炎ワクチンの企業別販売量・売上 ・B型肝炎ワクチンの企業別市場シェア ・B型肝炎ワクチンの世界市場規模 2016年-2021年：種類別（酵母由来、CHO由来） ・B型肝炎ワクチンの世界市場規模 2016年-2021年：用途別（子供、大人） ・B型肝炎ワクチンの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・B型肝炎ワクチンのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Hepatitis B Vaccines will have significant change from previous year. By the most conservative estimates of global Hepatitis B Vaccines market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 973 million in 2019. Over the next five years the Hepatitis B Vaccines market will register a 1.8% CAGR in terms of revenue, the global market size will reach US$ 1046.9 million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Hepatitis B Vaccines market by product type,...
  • 世界の小児用ワクチン市場予測 2021年-2026年
    LPI21MY9617 / LP Information / 2021年5月 / LPインフォメーション社の「小児用ワクチンの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、ジフテリア、インフルエンザ、肝炎、肺炎球菌性疾患、髄膜炎菌性疾患、その他など、用途別には、新生児、乳児、子供、青少年などにセグメント区分してまとめました。小児用ワクチンのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・小児用ワクチンの世界市場概要（サマリー） ・小児用ワクチンの企業別販売量・売上 ・小児用ワクチンの企業別市場シェア ・小児用ワクチンの世界市場規模 2016年-2021年：種類別（ジフテリア、インフルエンザ、肝炎、肺炎球菌性疾患、髄膜炎菌性疾患、その他） ・小児用ワクチンの世界市場規模 2016年-2021年：用途別（新生児、乳児、子供、青少年） ・小児用ワクチンの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・小児用ワクチンのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Pediatric Vaccines will have significant change from previous year. By the most conservative estimates of global Pediatric Vaccines market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 28250 million in 2019. Over the next five years the Pediatric Vaccines market will register a 5.9% CAGR in terms of revenue, the global market size will reach US$ 35510 million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Pediatric Vaccines market by product type, application, key manufacturers and...
  • 世界のPRRSワクチン市場予測 2021年-2026年
    LPI21MY6857 / LP Information / 2021年5月 / LPインフォメーション社の「PRRSワクチンの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、生ワクチン、不活化ワクチンなど、用途別には、政府入札、市場販売などにセグメント区分してまとめました。PRRSワクチンのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・PRRSワクチンの世界市場概要（サマリー） ・PRRSワクチンの企業別販売量・売上 ・PRRSワクチンの企業別市場シェア ・PRRSワクチンの世界市場規模 2016年-2021年：種類別（生ワクチン、不活化ワクチン） ・PRRSワクチンの世界市場規模 2016年-2021年：用途別（政府入札、市場販売） ・PRRSワクチンの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・PRRSワクチンのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of PRRS Vaccines will have significant change from previous year. By the most conservative estimates of global PRRS Vaccines market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the PRRS Vaccines market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of PRRS Vaccines market by product type, application, key manufacturers and...
  • 世界の多汗症におけるエネルギー装置市場予測 2021年-2026年
    LPI21MY8966 / LP Information / 2021年5月 / LPインフォメーション社の「多汗症におけるエネルギー装置の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、レーザー装置、マイクロ波装置、超音波装置など、用途別には、病院＆クリニック、ビューティーサロンなどにセグメント区分してまとめました。多汗症におけるエネルギー装置のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・多汗症におけるエネルギー装置の世界市場概要（サマリー） ・多汗症におけるエネルギー装置の企業別販売量・売上 ・多汗症におけるエネルギー装置の企業別市場シェア ・多汗症におけるエネルギー装置の世界市場規模 2016年-2021年：種類別（レーザー装置、マイクロ波装置、超音波装置） ・多汗症におけるエネルギー装置の世界市場規模 2016年-2021年：用途別（病院＆クリニック、ビューティーサロン） ・多汗症におけるエネルギー装置の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・多汗症におけるエネルギー装置のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Energy Based Device in Hyperhidrosis will have significant change from previous year. By the most conservative estimates of global Energy Based Device in Hyperhidrosis market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Energy Based Device in Hyperhidrosis market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Energy...
  • 世界のDNAプローブ診断市場予測 2021年-2026年
    LPI21MY8936 / LP Information / 2021年5月 / LPインフォメーション社の「DNAプローブ診断の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、DNAプローブ製品、標的配列直接検出、核酸増幅、DNAチップ遺伝子検出、DNAシーケンシング遺伝子検出など、用途別には、がん検診、感染症検査などにセグメント区分してまとめました。DNAプローブ診断のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・DNAプローブ診断の世界市場概要（サマリー） ・DNAプローブ診断の企業別販売量・売上 ・DNAプローブ診断の企業別市場シェア ・DNAプローブ診断の世界市場規模 2016年-2021年：種類別（DNAプローブ製品、標的配列直接検出、核酸増幅、DNAチップ遺伝子検出、DNAシーケンシング遺伝子検出） ・DNAプローブ診断の世界市場規模 2016年-2021年：用途別（がん検診、感染症検査） ・DNAプローブ診断の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・DNAプローブ診断のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of DNA Probe-based Diagnostic will have significant change from previous year. By the most conservative estimates of global DNA Probe-based Diagnostic market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the DNA Probe-based Diagnostic market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of DNA Probe-based Diagnostic market by product type,...
  • 世界のダニ媒介性脳炎ワクチン市場予測 2021年-2026年
    LPI21MY9672 / LP Information / 2021年5月 / LPインフォメーション社の「ダニ媒介性脳炎ワクチンの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、ヨーロッパTBEウイルス、極東TBEウイルス、シベリアTBEウイルスなど、用途別には、小児用ワクチン、成人用ワクチン、旅行者用ワクチンなどにセグメント区分してまとめました。ダニ媒介性脳炎ワクチンのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・ダニ媒介性脳炎ワクチンの世界市場概要（サマリー） ・ダニ媒介性脳炎ワクチンの企業別販売量・売上 ・ダニ媒介性脳炎ワクチンの企業別市場シェア ・ダニ媒介性脳炎ワクチンの世界市場規模 2016年-2021年：種類別（ヨーロッパTBEウイルス、極東TBEウイルス、シベリアTBEウイルス） ・ダニ媒介性脳炎ワクチンの世界市場規模 2016年-2021年：用途別（小児用ワクチン、成人用ワクチン、旅行者用ワクチン） ・ダニ媒介性脳炎ワクチンの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・ダニ媒介性脳炎ワクチンのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Tick-borne Encephalitis Vaccine will have significant change from previous year. By the most conservative estimates of global Tick-borne Encephalitis Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Tick-borne Encephalitis Vaccine market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Tick-borne Encephalitis Vaccine market by product type,...
  • 世界の微細藻類ベース水産飼料市場予測 2021年-2026年
    LPI21MY1932 / LP Information / 2021年5月 / LPインフォメーション社の「微細藻類ベース水産飼料の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、スピルリナ、クロレラ、テトラセルミス、イソクリシス、パブロバ、その他など、用途別には、幼生魚、軟体動物、甲殻類、その他などにセグメント区分してまとめました。微細藻類ベース水産飼料のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・微細藻類ベース水産飼料の世界市場概要（サマリー） ・微細藻類ベース水産飼料の企業別販売量・売上 ・微細藻類ベース水産飼料の企業別市場シェア ・微細藻類ベース水産飼料の世界市場規模 2016年-2021年：種類別（スピルリナ、クロレラ、テトラセルミス、イソクリシス、パブロバ、その他） ・微細藻類ベース水産飼料の世界市場規模 2016年-2021年：用途別（幼生魚、軟体動物、甲殻類、その他） ・微細藻類ベース水産飼料の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・微細藻類ベース水産飼料のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Microalgae-based Aquafeed will have significant change from previous year. By the most conservative estimates of global Microalgae-based Aquafeed market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Microalgae-based Aquafeed market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Microalgae-based Aquafeed market by product type, application, key manufacturers and...
  • 世界の植物性スクワラン市場予測 2021年-2026年
    LPI21MY2241 / LP Information / 2021年5月 / LPインフォメーション社の「植物性スクワランの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、オリーブスクワラン、砂糖由来スクワランなど、用途別には、化粧品＆パーソナルケア、医薬品、その他などにセグメント区分してまとめました。植物性スクワランのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・植物性スクワランの世界市場概要（サマリー） ・植物性スクワランの企業別販売量・売上 ・植物性スクワランの企業別市場シェア ・植物性スクワランの世界市場規模 2016年-2021年：種類別（オリーブスクワラン、砂糖由来スクワラン） ・植物性スクワランの世界市場規模 2016年-2021年：用途別（化粧品＆パーソナルケア、医薬品、その他） ・植物性スクワランの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・植物性スクワランのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Plant-based Squalane will have significant change from previous year. By the most conservative estimates of global Plant-based Squalane market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Plant-based Squalane market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Plant-based Squalane market by product type, application, key manufacturers and...

    • ◆H&Iグローバルリサーチのお客様（例）◆